The company in question is, Sanofi (NYSE:SNY) currently with a stock price of 42.1 (-0.02% today). The market cap for Sanofi is 107529.99, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Sanofi is 52. Currently Sanofi is trading with a P/E of 22.62, and a forward P/E of 13.3. Average volume for Sanofi is 2341.31 and so far today it is 465710.
Performance in the last year for Sanofi has been -17.72%. For EPS growth, Sanofi has seen a growth of 4.10%, and is looking to grow in the next year to 0.16%. More long term stats show that EPS growth has been -4.40% over the last five years and could be 7.10% for the next five years. Sanofi has seen sales growth quarter over quarter at -3.60%, with EPS growth quarter over quarter at 4.60%. The 20-day simple moving average is 3.60%, with the 200-day simple moving average coming to 2.81%.
Since the IPO date for Sanofi on the 7/1/2002, Sanofi has seen performance year to date to be 2.89%. With Sanofi trading at 42.1, the dividend yield is 3.94%, and the EPS is 1.86.
So could Sanofi, be undervalued? Well as said before P/E is 22.62. The PEG is 3.19, P/S is 2.82 and the P/B is at 1.72. The P/cash is *TBA, with P/free cash flow at *TBA.
Sanofi ability to deal with debt shows that the current ratio is *TBA, and the quick ratio is *TBA. This is with long term debt/equity at *TBA, and total debt/equity at *TBA.
In terms of margins, Sanofi has a gross margin of 68.80%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Sanofi is *TBA. Return on assets come to *TBA with return on investment coming to 6.50%.
Insider ownership for Sanofi, is at 16.40% and institutional ownership comes to 9.70%. Outstanding shares are at 2553.55. While shares float is 2304.36. The float short is currently 0.20%, and short ratio is 1.95.